Medifast, Inc. (MED) Stock Price
MEDStock
$11.88−7.62%52W
Market Cap$132.83M
P/E—
PEG Ratio0.97
Div yield9.97%
Beta0.70
MED Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-0.71%
Price vs S&P 500 (4W)-1.77%
PEG Ratio0.97
VGM Score41.44
Indicated Dividend Yield (Annual)9.97%
MED Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | -$0.65 | -$0.28 | +56.92%(+$0.37) | |
| Q1 2026 | -$0.52 | -$0.19 | +63.46%(+$0.33) | |
| Q4 2025 | -$0.82 | -$1.65 | -101.22%(-$0.83) | |
| Q3 2025 | -$0.36 | -$0.21 | +41.67%(+$0.15) | |
| Q2 2025 | -$0.19 | $0.22 | +215.79%(+$0.41) |
MED Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
2.33
2.33
2.33
2.33
Industry Peers — Miscellaneous Food Products(6)
| Symbol | Value Score | Growth Score | Momentum Score | P/E Ratio (Annual) | ROE (TTM) | Revenue Growth (5Y) | Indicated Dividend Yield (Annual) | Price |
|---|---|---|---|---|---|---|---|---|
MEDMedifast, Inc. | C | F | B | — | -12.7% | -16.2% | 10.0% | $11.88 |
| MKC.VMcCormick & Company, Incorporated Voting CS | C | C | C | 15.8x | 22.3% | 4.1% | 2.3% | $46.88 |
| MKCMcCormick & Company, Incorporated Non-VTG CS | C | C | C | 15.8x | 22.3% | 4.1% | 2.3% | $46.35 |
| UTZUtz Brands, Inc. | D | D | A | 2571.5x | -4.1% | 8.3% | 1.7% | $14.29 |
| JVACoffee Holding Co., Inc. | A | C | B | 18.5x | 16.2% | 7.8% | 2.3% | $4.56 |
| TWGTop Wealth Group Holding Limited Class A Ordinary Shares | B | B | F | 1.2x | 6.0% | — | — | $0.06 |
| FARMFarmer Bros Co | A | D | D | — | -47.6% | -7.3% | — | $0.00 |
About Medifast, Inc.
Medifast Inc provides obesity and weight management solutions through OPTAVIA, a coach-guided platform combining personalized nutrition, behavioral coaching, and community support. The company offers access to GLP-1 medications where clinically appropriate to complement its core lifestyle program. OPTAVIA's model focuses on habit-based change and long-term health outcomes, positioning the company in the growing weight management market.